SLC3A2 and neoplasm: Moreover, SLC3A2 expression increased during progression, as Tfh tumor cells in the relapsed/refractory (RR) group expressed higher levels of SLC3A2 than those in the newly diagnosed (ND) group (Figure 3B,C).